Press Releases Paxman AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-27 EDT			5-day change	1st Jan Change
46.2 ^SEK	+0.87%		+2.67%	+25.54%

05-23	Paxman AB Appoints Karen Giddings Clakely to the Board	CI
05-23	Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press release from PAXMAN AB’s 2024 Annual General Meeting	05-23	AQ
PAXMAN publishes its interim report for Q1 2024	05-23	AQ
Paxman publishes the company’s annual report for 2023	04-26	AQ
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.	04-19	AQ
See Redeye's interview with CEO Richard Paxman	02-23	AQ
Record year for Paxman!	02-23	AQ
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm	11-29	AQ
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November	11-27	AQ
See Redeye's interview with CEO Richard Paxman	11-17	AQ
PAXMAN publishes its interim report for Q3 2023	11-17	AQ
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023	11-10	AQ
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024	11-07	AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03	AQ
See Redeye's interview with CEO Richard Paxman	23-08-25	AQ
PAXMAN publishes its interim report for Q2 2023	23-08-24	AQ
PAXMAN announces proposal for Local Coverage Determination of scalp cooling therapy	23-06-15	AQ
See Redeye's interview with CEO Richard Paxman	23-05-25	AQ
Press release from PAXMAN AB’s 2023 Annual General Meeting	23-05-24	AQ
PAXMAN publishes its interim report for Q1 2023	23-05-24	AQ
Paxman publishes the company’s annual report for 2022	23-05-04	AQ

No results for this search